These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17640509)

  • 1. Beyond the Blue Book. Framework for Risk/Safety Assessment of Transgenic Plants. An overview of the workshop.
    Kobayashi M; Kearns P
    Environ Biosafety Res; 2006; 5(4):207-9. PubMed ID: 17640509
    [No Abstract]   [Full Text] [Related]  

  • 2. Basic framework for risk assessment for transgenic plants developed by the OECD: 20 years after the OECD "Blue Book".
    Bergmans H
    Environ Biosafety Res; 2006; 5(4):213-8. PubMed ID: 17640511
    [No Abstract]   [Full Text] [Related]  

  • 3. The Japanese experience with the Blue Book and subsequent activities in environmental biosafety of GM crops.
    Hayashi K
    Environ Biosafety Res; 2006; 5(4):237-8. PubMed ID: 17640516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspective on OECD activities from a non-member country.
    Alexandrova N; Atanassov A
    Environ Biosafety Res; 2006; 5(4):227-31. PubMed ID: 17640514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic crops from another perspective.
    Auberson L
    Trends Biotechnol; 2000 Oct; 18(10):404-5. PubMed ID: 11183126
    [No Abstract]   [Full Text] [Related]  

  • 6. 9th International Symposium on the Biosafety of Genetically Modified Organisms. Session VI: Estimating likelihood and exposure, Part II.
    Quemada H
    Environ Biosafety Res; 2006; 5(4):197-9. PubMed ID: 17640507
    [No Abstract]   [Full Text] [Related]  

  • 7. The OECD Blue Book on Recombinant DNA Safety Considerations: it's influence on ISBR and EFSA activities.
    Schiemann J
    Environ Biosafety Res; 2006; 5(4):233-5. PubMed ID: 17640515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically modified crops: success, safety assessment, and public concern.
    Singh OV; Ghai S; Paul D; Jain RK
    Appl Microbiol Biotechnol; 2006 Aug; 71(5):598-607. PubMed ID: 16639559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 9th International Symposium on the Biosafety of Genetically Modified Organisms. Session IV: Identifying and defining hazards and potential consequences III: Concepts for problem formulation and non-target risk assessment.
    Alvarez-Morales A
    Environ Biosafety Res; 2006; 5(4):189-92. PubMed ID: 17640505
    [No Abstract]   [Full Text] [Related]  

  • 10. 9th International Symposium on the Biosafety of Genetically Modified Organisms. Session VII: Risk management and monitoring.
    Schiemann J
    Environ Biosafety Res; 2006; 5(4):201-3. PubMed ID: 17640508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 9th International Symposium on the Biosafety of Genetically Modified Organisms. Session V: Estimating likelihood and exposure.
    Lentini Z
    Environ Biosafety Res; 2006; 5(4):193-5. PubMed ID: 17640506
    [No Abstract]   [Full Text] [Related]  

  • 12. Transgenic or not? No simple answer! New biotechnology-based plant breeding techniques and the regulatory landscape.
    Podevin N; Devos Y; Davies HV; Nielsen KM
    EMBO Rep; 2012 Dec; 13(12):1057-61. PubMed ID: 23154464
    [No Abstract]   [Full Text] [Related]  

  • 13. Biosafety and risk assessment framework for selectable marker genes in transgenic crop plants: a case of the science not supporting the politics.
    Ramessar K; Peremarti A; Gómez-Galera S; Naqvi S; Moralejo M; Muñoz P; Capell T; Christou P
    Transgenic Res; 2007 Jun; 16(3):261-80. PubMed ID: 17436060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current harmonization activities related to risk/safety assessment by the OECD Working Group on Harmonization of Regulatory Oversight in Biotechnology.
    MacDonald P; Yarrow S
    Environ Biosafety Res; 2006; 5(4):223-5. PubMed ID: 17640513
    [No Abstract]   [Full Text] [Related]  

  • 15. Auf Wiedersehen, agbiotech.
    Miller HI
    Nat Biotechnol; 2008 Sep; 26(9):974-5. PubMed ID: 18779798
    [No Abstract]   [Full Text] [Related]  

  • 16. Status of market, regulation and research of genetically modified crops in Chile.
    Sánchez MA; León G
    N Biotechnol; 2016 Dec; 33(6):815-823. PubMed ID: 27474111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating biological variation in non-transgenic crops: executive summary from the ILSI Health and Environmental Sciences Institute workshop, November 16-17, 2009, Paris, France.
    Doerrer N; Ladics G; McClain S; Herouet-Guicheney C; Poulsen LK; Privalle L; Stagg N
    Regul Toxicol Pharmacol; 2010 Dec; 58(3 Suppl):S2-7. PubMed ID: 20615445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promise and issues of genetically modified crops.
    Chen H; Lin Y
    Curr Opin Plant Biol; 2013 May; 16(2):255-60. PubMed ID: 23571013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procedure to select test organisms for environmental risk assessment of genetically modified crops in aquatic systems.
    Hilbeck A; Bundschuh R; Bundschuh M; Hofmann F; Oehen B; Otto M; Schulz R; Trtikova M
    Integr Environ Assess Manag; 2017 Nov; 13(6):974-979. PubMed ID: 28755496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trace and traceability--a call for regulatory harmony.
    Ramessar K; Capell T; Twyman RM; Quemada H; Christou P
    Nat Biotechnol; 2008 Sep; 26(9):975-8. PubMed ID: 18779799
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.